Biolase gets US nod for eye laser:
This article was originally published in Clinica
Marking an "important milestone in its ophthalmic pursuits", Biolase Technology, a company that makes laser systems for use primarily in dentistry, has gained US clearance to sell its Oculase MD laser system for general ophthalmic soft tissue surgical indications. The approval represents an "early achievement along the path to developing a treatment for presbyopia", said the Irvine, California firm. It also enables Biolase to pursue other applications using its core technology in ophthalmology, and will improve its ability to move forward with its clinical research and sales and marketing initiatives for Oculase MD, both domestically and internationally, said the company. Oculase MD is the first Er,Cr:YSGG laser system cleared for ophthalmic applications, Biolase added.